BASIS OF PRESENTATION AND DESCRIPTION OF BUSINESS (Details Narrative) - $ / shares |
9 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2019 |
Jul. 12, 2019 |
Jan. 18, 2019 |
Sep. 30, 2018 |
|
| Common stock, issued | 2,829,248 | 56,466,428 | 2,829,248 | |
| Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
| Financing Agreements [Member] | NeuBase Therapeutics, Inc [Member] | ||||
| Discription of ownership hold | Alongside the closing of the Merger, NeuBase completed two financings raising gross proceeds of approximately $14 million, and we believe that our current cash balance will be sufficient to fund our operating expenses and capital expenditure requirements for at least the next 12 months from issuance of the financial statements as of, and for the period ended, June 30, 2019. | |||
| Common stock, issued | 1.019055643 |